J1931 Injection, laronidase, 0.1 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Laronidase injection
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, laronidase, 0.1 mg | yes |
Related codes in J19
- J1920 Injection, labetalol hydrochloride, 5 mg
- J1921 Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
- J1930 Injection, lanreotide, 1 mg
- J1932 Injection, lanreotide, (cipla), 1 mg
- J1938 Injection, furosemide, 1 mg
- J1939 Injection, bumetanide, 0.5 mg
- J1941 Injection, furosemide (furoscix), 20 mg
- J1943 Injection, aripiprazole lauroxil, (aristada initio), 1 mg
- J1944 Injection, aripiprazole lauroxil, (aristada), 1 mg
- J1950 Injection, leuprolide acetate (for depot suspension), per 3.75 mg
- J1951 Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
- J1952 Leuprolide injectable, camcevi, 1 mg
- J1953 Injection, levetiracetam, 10 mg
- J1954 Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg
- J1955 Injection, levocarnitine, per 1 gm
- J1956 Injection, levofloxacin, 250 mg
- J1960 Injection, levorphanol tartrate, up to 2 mg
- J1961 Injection, lenacapavir (only for use as hiv treatment), 1 mg
- J1980 Injection, hyoscyamine sulfate, up to 0.25 mg
- J1990 Injection, chlordiazepoxide hcl, up to 100 mg